One hundred consecutive isolated limb perfusions with TNF-alpha and melphalan in melanoma patients with multiple in-transit metastases.
about
Pharmacological manipulation of cell death: clinical applications in sight?Isolated limb perfusion for malignant melanoma: systematic review on effectiveness and safetyRegional therapies for in-transit diseaseThe European approach to in-transit melanoma lesions.Long-term outcome of isolated limb perfusion with tumour necrosis factor-α for patients with melanoma in-transit metastases.20 years experience of TNF-based isolated limb perfusion for in-transit melanoma metastases: TNF dose mattersLong-term results of hyperthermic, isolated limb perfusion for melanoma: a reflection of tumor biology.History of regional chemotherapy for cancer of the extremities.Toxicities associated with hyperthermic isolated limb perfusion and isolated limb infusion in the treatment of melanoma and sarcoma.Future directions in regional treatment strategies for melanoma and sarcoma.Surgery and radiotherapy in the treatment of cutaneous melanomaPharmacotherapy of regional melanoma therapy.Synergy in cancer treatment between liposomal chemotherapeutics and thermal ablation.Regional treatment strategies for in-transit melanoma metastasis.Isolated limb perfusion for in-transit melanoma metastases: melphalan or TNF-melphalan perfusion?Sentinel Lymph Node Biopsy for Recurrent Melanoma: A Multicenter Study.Regional hyperthermic perfusion with melphalan after surgery for recurrent malignant melanoma of the extremities--long-term follow-up of a randomised trial.Treatment of locally advanced melanoma by isolated limb infusion with cytotoxic drugsSurgical management of melanoma: an EORTC Melanoma Group survey.Anti-tumor action of tumor necrosis factor against Bomirski Ab melanoma in hamsters.Radionuclide leakage monitoring during hyperthermic isolated limb perfusion for treatment of local melanoma metastasis in an extremity.Long-term follow-up of 163 consecutive patients treated with isolated limb perfusion for in-transit metastases of malignant melanoma.Phase I/II study of topical imiquimod and intralesional interleukin-2 in the treatment of accessible metastases in malignant melanoma.High response rate after intratumoral treatment with interleukin-2
P2860
Q24536101-44DDE3CB-A5A6-414F-82B3-B02780FD244BQ24633360-3C15A82C-4AAF-4276-BDE8-F656CF9DDED1Q28087553-4EA9A15E-F3D4-4AC8-9012-55675E052BDFQ33327121-D1ED4838-2514-44F7-883D-8C6234540CB8Q33955599-19AC998A-F342-4CA1-8F40-1A17F4741C1EQ34006197-E4DB5FF2-0B94-4C99-B275-5ED56178F5B0Q36783761-EDA574A1-283E-4F9E-A6A0-A4DA0FADD13AQ37130233-C7E0A81F-2E52-48B9-8961-B010FB124EE6Q37130257-515E7065-97D9-47DD-9846-E7C037B74644Q37130262-D3C1F336-9B3C-489F-85E2-717B16DB3884Q37266677-1F29E3D8-9C3D-42AC-8D6E-034A926C7DD6Q37650312-FF3C450A-4BC9-40C6-9FFD-0C6399C1AEC3Q37727030-3867328B-AE1F-4062-A74E-EAA638700228Q37812815-9FA588EA-DAE5-4EF1-BF64-8C6B1BD54605Q38176854-91A8CCD2-F7E7-4357-8FCF-4FB2F3FD4325Q38784286-533C7F06-8BCD-4BDC-83B6-AF663DF5CB19Q39141902-A7F11727-17B0-450E-8A89-137940C05A4AQ39720293-F4904FA3-9DBA-428F-B8A9-E89D4D2FE635Q39743860-F80AE455-3FB0-41C1-8F77-CE3004E6A6D2Q40101284-1E182428-F0EB-41F6-B547-63991E899B1BQ44862870-BE019968-EB0A-45AC-B77E-2C6AFFAE7386Q47985650-AFE51339-D3AA-453F-B84F-0AF8D208EB4EQ50701417-AD41CCAC-9744-4BFB-9E5A-E160EE7F226DQ56986750-4F6B1EE6-B4A5-4039-B78B-7205BFB377F7
P2860
One hundred consecutive isolated limb perfusions with TNF-alpha and melphalan in melanoma patients with multiple in-transit metastases.
description
2004 nî lūn-bûn
@nan
2004 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
One hundred consecutive isolat ...... ultiple in-transit metastases.
@ast
One hundred consecutive isolat ...... ultiple in-transit metastases.
@en
type
label
One hundred consecutive isolat ...... ultiple in-transit metastases.
@ast
One hundred consecutive isolat ...... ultiple in-transit metastases.
@en
prefLabel
One hundred consecutive isolat ...... ultiple in-transit metastases.
@ast
One hundred consecutive isolat ...... ultiple in-transit metastases.
@en
P2093
P2860
P1433
P1476
One hundred consecutive isolat ...... ultiple in-transit metastases.
@en
P2093
Albertus N van Geel
Alexander M M Eggermont
Dirk J Grünhagen
Flavia Brunstein
Johannes H W de Wilt
Wilfried J Graveland
P2860
P304
939-47; discussion 947-8
P356
10.1097/01.SLA.0000146147.89667.ED
P407
P577
2004-12-01T00:00:00Z